Sustainable Nanotechnologies Derived from Renewable Resources for Advanced Drug Design, Delivery and Therapy

Dear Colleagues,

Sustainable nanotechnologies derived from renewable biological resources have emerged as a strategic approach to the development of advanced drug delivery systems, integrating therapeutic efficiency, safety, and environmental responsibility. The incorporation of natural polymers, renewable bioactive molecules, and eco-friendly synthetic processes enables the design of nanoarchitectures with high biocompatibility, functional versatility, and superior pharmaceutical performance. In parallel, the use of green materials and low-impact synthetic pathways reduces chemical waste, energy consumption, and dependence on petrochemical sources. This Special Issue aims to gather scientific contributions on topics ranging from the molecular design to the therapeutic application of sustainable nanomaterials, including nanoemulsions, nanogels, hybrid nanocarriers, green-synthesized metallic nanoparticles, natural photosensitizing systems, and platforms for combined therapies. Emphasis will be placed on studies demonstrating advances in the mechanisms of action, physicochemical modeling, nano–bio interactions, and preclinical evaluation of sustainable nanomaterials, and their impact on oncology, infectious diseases, inflammation, and parasitic disorders. By promoting integrated discussions across green chemistry, pharmaceutical nanotechnology, and translational medicine, this Special Issue seeks to encourage the development of innovative, safe, and sustainable solutions to current challenges in drug design, delivery, and therapy.

Dr. Renato Sonchini Gonçalves
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.